Faeth Therapeutics, Inc FTH

US Biotechnology

$12.25 ▼ -3.39% ($-0.43)

🔥 High Short Interest

Open $12.54

Prev Close $12.68

Day Range $11.80 – $13.94

52W Range $10.45 – $42.14

Market Cap $327.70M

Beta 2.70

EPS (TTM) $-141.65

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2021-02-04
Shares Out.	25,840,000
Website	faeththerapeutics.com ↗
Phone	18008998648
Employees	29
Revenue	$0
Gross Profit	$0
Net Income	-$20.4M
Free Cash Flow	-$43.3M
Total Assets	$178.9M
Total Liabilities	$11.1M
Equity	$161.1M

About Faeth Therapeutics, Inc

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Faeth Therapeutics, Inc is a publicly traded company under the ticker symbol FTH on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.